"Affidea Praha s.r.o. - Chodov je soukromé ambulantní zdravotnické zařízení, které má smlouvu se všemi pojišťovnami, poskytuje vysoce specialisovanou diagnostiku a léčebnou péči v oborech kardiologie, interna, angiologie, endokrinologie, revmatologie, osteologie, neurologie, nefrologie. K dispozici je kompletní sonografie, CT, magnetická rezonance, denzitometrie a kompletní laboratoř. Dále nabízíme pracovně lékařskou službu, preventivní prohlídky, poradnu pro cesty do zahraničí, očkování atd. Od zahájení provozu jsme vyšetřili více než 300 000 pacientů."

During the past decade, Affidea Praha s.r.o conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 9 clinical trials were completed, i.e. on average, 81.8% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Affidea Praha s.r.o" #1 sponsor was "Pfizer" with 5 trials, followed by "Amgen" with 2 trials sponsored, "R-Pharm International, LLC" with 2 trials sponsored, "Bayer" with 1 trials sponsored and "Celgene" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Affidea Praha s.r.o" #1 collaborator was "OCT Clinical Trials" with 2 trials as a collaborator, "ArthroLab Inc." with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "IQVIA Pvt. Ltd" with 1 trials as a collaborator and "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Affidea Praha s.r.o" are "Rheumatoid Arthritis" (5 trials), "Psoriatic Arthritis" (3 trials), "Spondylitis, Ankylosing" (3 trials), "Ankylosing Spondylitis" (2 trials) and "Osteoarthritis" (2 trials). Many other conditions were trialed in "Affidea Praha s.r.o" in a lesser frequency.

Most popular intervention types in "Affidea Praha s.r.o" are "Drug" (16 trials), "Other" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Apremilast 20mg" (2 trials), "Apremilast 30mg" (2 trials), "Adalimumab 40mg q2w" (1 trials) and "Background NSAID" (1 trials). Other intervention names were less common.

The vast majority of trials in "Affidea Praha s.r.o" are 15 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Affidea Praha s.r.o". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Affidea Praha s.r.o, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Affidea Praha s.r.o, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".